Cargando…

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Quittner, Alexandra L, Abbott, Janice, Georgiopoulos, Anna M, Goldbeck, Lutz, Smith, Beth, Hempstead, Sarah E, Marshall, Bruce, Sabadosa, Kathryn A, Elborn, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717439/
https://www.ncbi.nlm.nih.gov/pubmed/26452630
http://dx.doi.org/10.1136/thoraxjnl-2015-207488
_version_ 1782410657664073728
author Quittner, Alexandra L
Abbott, Janice
Georgiopoulos, Anna M
Goldbeck, Lutz
Smith, Beth
Hempstead, Sarah E
Marshall, Bruce
Sabadosa, Kathryn A
Elborn, Stuart
author_facet Quittner, Alexandra L
Abbott, Janice
Georgiopoulos, Anna M
Goldbeck, Lutz
Smith, Beth
Hempstead, Sarah E
Marshall, Bruce
Sabadosa, Kathryn A
Elborn, Stuart
author_sort Quittner, Alexandra L
collection PubMed
description Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.
format Online
Article
Text
id pubmed-4717439
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47174392016-01-28 International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety Quittner, Alexandra L Abbott, Janice Georgiopoulos, Anna M Goldbeck, Lutz Smith, Beth Hempstead, Sarah E Marshall, Bruce Sabadosa, Kathryn A Elborn, Stuart Thorax Cystic Fibrosis Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use. BMJ Publishing Group 2016-01 2015-10-09 /pmc/articles/PMC4717439/ /pubmed/26452630 http://dx.doi.org/10.1136/thoraxjnl-2015-207488 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Cystic Fibrosis
Quittner, Alexandra L
Abbott, Janice
Georgiopoulos, Anna M
Goldbeck, Lutz
Smith, Beth
Hempstead, Sarah E
Marshall, Bruce
Sabadosa, Kathryn A
Elborn, Stuart
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title_full International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title_fullStr International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title_full_unstemmed International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title_short International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
title_sort international committee on mental health in cystic fibrosis: cystic fibrosis foundation and european cystic fibrosis society consensus statements for screening and treating depression and anxiety
topic Cystic Fibrosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717439/
https://www.ncbi.nlm.nih.gov/pubmed/26452630
http://dx.doi.org/10.1136/thoraxjnl-2015-207488
work_keys_str_mv AT quittneralexandral internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT abbottjanice internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT georgiopoulosannam internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT goldbecklutz internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT smithbeth internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT hempsteadsarahe internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT marshallbruce internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT sabadosakathryna internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety
AT elbornstuart internationalcommitteeonmentalhealthincysticfibrosiscysticfibrosisfoundationandeuropeancysticfibrosissocietyconsensusstatementsforscreeningandtreatingdepressionandanxiety